Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-Acetyl-L-Leucine in CACNA1A Disorders
NCT07221292Phase 3Active, not recruiting
- Sponsor
- IntraBio
- Start
- Aug 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 7
01
Overview
A Phase 3 trial of levacetylleucine in CACNA1A-related disorder (CACNA1A), sponsored by IntraBio. Started Aug 2026; status: active, not recruiting.
02
Drugs
levacetylleucine
03
Conditions
CACNA1A-related disorder (CACNA1A)
Beyond the preview
Go deeper on NCT07221292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07221292.